The global Gene Therapy Market is expected to expand at a healthy CAGR over the forecast period (from 2017 to 2025). Gene therapy is a clinical treatment that involves the usage of specific types of genes in order to treat or prevent various diseases. It can also treat a number of hereditary disorders wherein the defective genes are replaced with the functional ones. Rising cases of chronic and life-threatening ailments and increased focus on boosting commercialization of gene therapy in developed regions can drive the global market. In addition, failure of traditional treatments and therapies is also expected to augment the demand for gene therapy in cancer treatment, thereby boosting the growth of the global market.
On the other hand, high cost associated with various gene therapy drugs along with safety concerns and strict regulatory laws may have a negative impact on the market development. Moreover, challenges in commercialization of gene therapy may also hinder the market growth over the forecast period. However, rise in funding for research and development activities and increased awareness levels about gene therapy are predicted to propel the market in the forthcoming years. Gene therapy has emerged as a potential treatment solution for a number of diseases including several types of cancers, genetic disorders, and viral infections. This factor is likely to contribute toward the expansion of gene therapy market. Growing target population is also expected to impel the demand for gene therapy during the next few years.
In addition, various technological developments and pre-clinical and clinical assessments for the treatment of a variety of diseases are also projected to propel the growth of the gene therapy market in near future. Furthermore, successful trials for the treatment of disorders related to central nervous system (CNS) are predicted to offer new opportunities for the global market. Increased R&D investments by various governments and several international companies for the development of safe and effective therapies would also spur the market growth.
Access Sample Report of this report @ https://www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020/request-sample
The global gene therapy market is categorized on the basis of application and region. Based on application, the market is segmented into Cardiovascular Diseases (CVDs), genetic diseases, oncology, infectious diseases, neurological diseases, and others. Based on region, the market is divided into Europe, Asia, North America, and Rest of the World (RoW). The North America region is anticipated to be the dominant regional market by 2025. Presence of highly developed health care facilities, favorable reimbursement policies, extensive R&D, and higher healthcare expenditure are the key growth drivers. Europe is expected to follow the North America regional market. On the other hand, The Asia Pacific regional market is projected to register maximum growth rate from 2017 to 2025. Key factors driving Asia Pacific market include growing cases of cancer, supportive government initiatives to enhance healthcare infrastructure, and increased healthcare expenditure. China, in particular, is predicted to witness the maximum growth in the Asia Pacific region over the forecast years.
Sibiono GeneTech Co. Ltd.; Human Stem Cells Institute; Shanghai Sunway Biotech Co. Ltd.; ViroMed Co. Ltd. dba VM BioPharma; and Spark Therapeutics, LLC are some of the key players in the gene therapy market. The recent development in the market includes the usage of gene therapy for the treatment of idiopathic pulmonary fibrosis (IPF). Recently, experts at the Telomere and Telomerase Group at the Spanish Cancer Research Centre successfully cured IPF in mice with the help of a gene therapy that lengthens the telomeres.
Browse Full Report With TOC @ https://www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020
Table of Contents
1. Analyst View
2. Research Methodology
3. Gene Therapy – An Introduction
3.1 Classification of Gene Therapy Techniques
3.2 Physical Methods of Gene Transfer
3.2.1 Electroporation
3.2.2 Hydrodynamic
3.2.3 Microinjection
3.2.4 Particle Bombardment
3.2.5 Ultrasound-Mediated Transfection
3.3 Vectors for Gene Therapy
3.3.1 Viral Vectors
3.3.1.1 Adenoviral Vectors
3.3.1.2 Adeno-associated Virus Vectors
3.3.1.3 Retroviral Vectors
3.3.1.4 Lentiviral Vectors
3.3.2 Non Viral Vectors
3.3.2.1 Naked DNA/Plasmid Vectors
3.3.2.2 Oligonucleotides
3.3.2.3 Liposomes, Lipoplexes and Polyplexes
3.3.2.4 Gene-Activated Matrix
Browse reports of similar category available with Radiant Insights, Inc.:
- Dentistry Market –
https://www.radiantinsights.com/research/global-dentistry-market-size-status-and-forecast-2025
- Opioid Induced Constipation Drugs Market –
About Radiant Insight
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.radiantinsights.com/research/global-and-us-gene-therapy-market-forecast-to-2020